Clinical Trial Update: Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating trastuzumab in combination with exemestane for postmenopausal women with metastatic or locally advanced breast cancer has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN